Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10683277
Triazole derivatives as P2Y14 receptor antagonists
granted -
US 10682425
Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them
granted -
US 10682416
Epicardial-derived paracrine factors for repairing cardiac tissue
granted -
US 10682379
Use of gram negative species to treat atopic dermatitis
granted -
US 10682393
Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
granted -
US 10682388
Targeting of PELP1 in cancer therapy
granted -
US 10682339
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same
granted -
US 10683362
Recombinant immunotoxin targeting mesothelin
granted -
US 10683270
Cannabinoid receptor mediating compounds
granted -
US 10682310
Therapeutic compounds and formulations for intranasal delivery
granted -
US 10683279
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 10683272
Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
granted -
US 10682350
2,4-pyrimidinediamine compounds and their uses
granted -
US 10682418
Polymer-sunitinib conjugates
granted -
US 10683347
Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies
granted -
US 10683363
Targeting intracellular target-binding determinants with intracellular antibodies
granted -
AU 2018379646
Dopamine-B-hydroxylase inhibitors
granted -
US 10675272
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
granted -
US 10676530
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
granted -
US 10675358
Antibody adjuvant conjugates
granted -
US 10675258
Method of using gamma-hydroxybutyrate compositions for the treatment of disorders
granted -
US 10675304
Combination immunotherapies for treatment of cancer
granted -
US 10676474
1,6-naphthyridine derivatives as CDK4/6 inhibitor
granted -
US 10675341
Parenteral norovirus vaccine formulations
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.